Guobang Pharma Ltd banner
G

Guobang Pharma Ltd
SSE:605507

Watchlist Manager
Guobang Pharma Ltd
SSE:605507
Watchlist
Price: 26.39 CNY -0.49% Market Closed
Market Cap: ¥14.7B

Wall Street
Price Targets

Price Targets Summary
Guobang Pharma Ltd

Wall Street analysts forecast Guobang Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Guobang Pharma Ltd is 28.96 CNY with a low forecast of 28.67 CNY and a high forecast of 29.81 CNY.

Lowest
Price Target
28.67 CNY
9% Upside
Average
Price Target
28.96 CNY
10% Upside
Highest
Price Target
29.81 CNY
13% Upside
Guobang Pharma Ltd Competitors:
Price Targets
JEF
Jefferies Financial Group Inc
105% Upside
OBT
Orange County Bancorp Inc
21% Upside

Revenue
Forecast

9% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
9% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 5 years the compound annual growth rate for Guobang Pharma Ltd's revenue is 9%. The projected CAGR for the next 3 years is 15%.

Operating Income
Forecast

8% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
8% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 5 years the compound annual growth rate for Guobang Pharma Ltd's operating income is 8%. The projected CAGR for the next 3 years is 21%.

Net Income
Forecast

20% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
20% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 5 years the compound annual growth rate for Guobang Pharma Ltd's net income is 20%. The projected CAGR for the next 3 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Guobang Pharma Ltd's stock price target?
Price Target
28.96 CNY

According to Wall Street analysts, the average 1-year price target for Guobang Pharma Ltd is 28.96 CNY with a low forecast of 28.67 CNY and a high forecast of 29.81 CNY.

What is Guobang Pharma Ltd's Revenue forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for Guobang Pharma Ltd's revenue is 9%. The projected CAGR for the next 3 years is 15%.

What is Guobang Pharma Ltd's Operating Income forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for Guobang Pharma Ltd's operating income is 8%. The projected CAGR for the next 3 years is 21%.

What is Guobang Pharma Ltd's Net Income forecast?
Projected CAGR
22%

For the last 5 years the compound annual growth rate for Guobang Pharma Ltd's net income is 20%. The projected CAGR for the next 3 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett